Since miR-155 has been reported to cause transition of cancer cells exhibiting an epithelial-like phenotype to a more mesenchymal-like phenotype, we evaluated possible changes in morphology and expression of E-cadherin (epithelial marker) and vimentin (mesenchymal marker) in our mesenchymal-like metastasis model. This evidence concerns the gene CDH1 and cancer.